The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Of course they got more information than us and they would have had the best advice too but companies still have no guarantees on the future, nobody does. As for Barclays advice they will send that to their customers who have paid for that advice. He is either a customer who is entitled to that analysis or more likely it was passed on to him like a book you've finished reading. Happens all the time. They would have been as open as they are permitted and it is not a good reputation to have of not following good governance with privileged information.
Boundaries get stretched but there are limits and EnQuest would be in serious trouble if they breach them. They know this and nothing in the past suggests to me that they leak privileged information.
Hello Romaron,
I think these cubas and helikon got a lot more information then us. Barclays must also got detailed information on for example Magnus production growth 2023. This Barclays analysis was not for retail owners, not sure how the Swedish guy got it.
Doubt cubas and Helikon would invest without seeing a 3-5 year Enquest plan what can be achieved on different oil price assumptions.
Good signs for the future
Hi Pelle - they would have spoken direct or even had a face to face meeting. They would not be given inside information but (for example) an astute interviewer or barrister can phrase questions to elicit an answer. It is actually sometimes easier to see evasion on someones's face or a quick glance at another member of the team can speak volumes. I got this from IR in August when I made a mistake over the swap thinking Helikon may have been sellers: "Helikon had expressed an interest in investing in EnQuest equity a few months ago and we have been helping them understand the business. They are interested in (and obviously supporters of) the free cash flow generating potential of the business. We do not see them as activist or shorting the stock."
As always it is about size. If you are a large holder you will be granted an interview or contemplating investing and going through due diligence. I doubt they'd offer me one but TBH I've never asked. You get pretty quick response by email and that's good enough enough for me. If people were that interested then there woud be more retail attendees at the AGM.
*If you really want to see complication try and get your head around this: https://www.foreignaffairs.com/articles/world/2021-11-30/geopolitics-energy-green-upheaval
when you bring the real world into the equation you see the potential for it going awfully wrong. The transition is going to be a lot longer than the ESG lobby is pushing for.
Jefferies also agree with JPM.. B of A was also saying the same things a couple of weeks ago ($120) mid 2022 if fully reopened
https://oilprice.com/Energy/Oil-Prices/Jefferies-Fully-Reopened-World-Could-See-150-Oil.html
I'm slightly concerned about the low $70s pricing which could be with us until next summer.. Tarmak has some excellent excel analysis but has used $85 as an estimate for Brent in 2022. Perhaps we can trend again to $80 next summer but there are some like Deutsche that last night were looking at $60 next summer. Others like JPM looking at much higher in 2H 2022 , but admitting an OPEC+ pause in Q1 next year will be required.
https://www.thestreet.com/investing/oil-will-hit-125-a-barrel-in-2022-150-in-2023-jpmorgan
Brent $80 plus is what Enquest needs to boost the SP.. but low $70s isn't enough to attract much attention, even though it generates good cashflow..
No idea but you can bet on it being more than what we get told
COBAS not looking a gift horse in the mouth.
If I had funds I would be loading up here too.
Santa rally should work out nicely when good data on omicron starts filtering through mid December.
What additional information do you guys think Enquest give to cobus?
Would be very interesting to see a list of our major shareholders averages are including AB
I bet most are high 30's
A good, a very good sign of confidence indeed, Cobas upping the stakes. I can't accentuate enough Cobas is an establishment with an EXCELLENT international reputation.
26-Nov-2021.. , they might have added even more over the last 2 days.
moving from 3% to 4% is a good move.. part of me thinks it brings down their average.
holding RNS.
Probably explains the recent strength